Tech Company Financing Transactions
MAIA Biotechnology Funding Round
MAIA Biotechnology closed a $33 million funding round on 4/8/2026. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/8/2026
Transaction Type
Debt
Amount
$33,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
444 West Lake Street 1700
Chicago, IL 60606
USA
Chicago, IL 60606
USA
Phone
Website
Email Address
Overview
Our mission is to research, develop, and deliver innovative medicines to improve and extend the lives of people with cancer. MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vlad Vitoc
Chief Financial Officer
Jeffrey Himmelreich
Chief Scientific Officer
Sergei Gryaznov
Browse more venture capital transactions:
Prev: 4/8/2026: Fieldwork Robotics venture capital transaction
Next: 4/8/2026: Petwealth venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs